Search

Your search keyword '"Debouverie, Marc"' showing total 384 results

Search Constraints

Start Over You searched for: "Debouverie, Marc" Remove constraint "Debouverie, Marc"
384 results on '"Debouverie, Marc"'

Search Results

4. Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study

5. Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal

7. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference

9. Comparison of 2 Methods for Estimating Multiple Sclerosis–Related Mortality

11. Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data

12. Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

13. Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.

14. Effects of High- and Low-Efficacy Therapy in Secondary Progressive Multiple Sclerosis

15. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

17. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

18. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

20. Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

21. The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial

22. Historique de la sclérose en plaques

23. Immunologie de la sclérose en plaques

24. Épidémiologie, environnement et génétique dans la sclérose en plaques

25. Histoire naturelle de la sclérose en plaques

26. The radiologically isolated syndrome: revised diagnostic criteria

27. Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis

28. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study

32. Disease Reactivation After Cessation of Disease-Modifying Therapy in Patients With Relapsing-Remitting Multiple Sclerosis

33. Evaluation of the quality of the care pathway for patients with multiple sclerosis in France: Results of an original study of a cohort of 700 patients

36. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.

37. Prospective Characterization of Brain T2 Lesions Suggestive of Demyelination in Asymptomatic Patients diagnosed as Radiologically Isolated Syndrome (P14-4.011)

38. Comparative effectiveness of dimethyl fumarate in multiple sclerosis

39. Adult-onset genetic leukoencephalopathies: A MRI pattern-based approach in a comprehensive study of 154 patients

40. Comparative effectiveness of natalizumab and fingolimod in subgroups of patients with relapsing-remitting multiple sclerosis from three international cohorts

41. Disability progression in multiple sclerosis patients using early first‐line treatments.

42. The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

43. Additional file 1 of Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data

44. Additional file 2 of Intra-database validation of case-identifying algorithms using reconstituted electronic health records from healthcare claims data

45. sj-pdf-1-msj-10.1177_1352458520980366.pdf – Supplemental material for Cumulative effects of therapies on disability in relapsing multiple sclerosis

46. Mass Cytometry Identifies Expansion of T-bet(+) B Cells and CD206(+) Monocytes in Early Multiple Sclerosis

47. sj-pdf-1-msj-10.1177_1352458520981300 – Supplemental material for Determinants of therapeutic lag in multiple sclerosis

48. The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies

49. Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis:A Subgroup Analysis From Three International Cohorts

Catalog

Books, media, physical & digital resources